Microglia-induced neuroinflammation plays a vital role in the etiology and progression of neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease and multiple sclerosis. The neuroprotective role of androgens, including testosterone and its metabolite dihydrotestosterone (DHT), has been increasingly demonstrated in these diseases, but few studies investigated the effects of androgen on neuroinflammation. This study investigated the role of DHT in lipopolysaccharide (LPS)-induced neuroinflammation, neuronal damage and behavioral dysfunction, as well as underlying mechanisms. We showed that DHT inhibited LPS-induced release of proinflammatory factors, including TNF-α, iNOS, NO, and PGE2 in BV2 cells and primary microglia by suppressing the TLR4-mediated NF-κB and MAPK p38 signaling pathways, thus protecting SH-SY5Y neurons from inflammatory damage induced by activated microglia. In an LPS-induced J o u r n a l P r e -p r o o f Journal Pre-proof 2 neuroinflammation mouse model, endogenous DHT depletion by castration exacerbated inflammatory responses by upregulating the levels of TNF-α, IL-1β, IL-6, iNOS, and COX-2 in the serum and brain by increasing the LR4-mediated NF-κB and MAPK pathways activation, but these effects were restored by exogenous DHT supplementation. Moreover, DHT also regulated the mRNA levels of the antiinflammatory cytokines IL-10 and IL-13 in the brain. In addition, DHT modulated the expression of Aβ, the apoptotic proteins caspase-3, Bcl-2, and Bax, and synaptophysin, as well as neuronal damage in LPS-treated mouse brains. Further behavioral tests revealed that DHT ameliorated LPS-induced spatial and learning impairment and motor incoordination, and partly improved the locomotor activity in LPS-injected mice.
A single dose of LPS (5 mg/kg body weight) was used to induce acute neuroinflammation (Oliveira-Lima et al., 2019) .
Cell viability assay
BV2 cells, primary mouse microglial cells and SH-SY5Y neurons were seeded in 96well culture plates at a density of 1 × 10 4 cells/well. Cell viability was evaluated at 24 h after treatment with the indicated drugs or conditioned medium by a Cell Counting kit-8 assay Beyotime, China) . A volume of 10 µl CCK-8 dye was added to each well, and then the plate was incubated for another 2 h in a humidified incubator at 37 °C. The optical density of each well was measured at a wavelength of 450 nm.
Enzyme-linked immunosorbent assay (ELISA)
The levels of TNF-α, IL-1β, IL-6, and PGE2 ((Novus Biological, Littleton, CO, USA)) in the cell culture medium, brain tissue homogenate and serum were measured with ELISA kits following the manufacturer's recommendations.
Griess assay
The nitric oxide (NO) level in the culture medium was determined by measuring nitrite, a stable NO catabolite, using the Griess reagent (Beyotime, China). BV2 microglial cells (1×10 5 cells/ml) were stimulated in 24-well plates with or without 10 nM DHT for 24 h prior to LPS (100 ng/ml) treatment for 24 h, and then 50 μl of each culture supernatant was mixed with an equal volume of Griess reagent at room temperature for 10 min. The absorbance was measured at a wavelength of 540 nm using an ELISA microplate reader, and the level of nitrite was calculated based on a standard sodium nitrite curve.
J o u r n a l P r e -p r o o f Journal Pre-proof 2.6. Immunocytochemistry BV2 cells and primary microglia were washed three times with 1× PBS, fixed with 4% paraformaldehyde for 20 min, permeabilized and blocked with 0.2% Triton X-100 and 10 % goat serum in PBS for 1 h. The glass slides were mounted and incubated with rabbit-anti-Iba-1 (1:500) or anti-GFAP (1:500) overnight at 4 °C in a humidified chamber. The next day, the cells were washed three times with 1 × PBS and incubated with goat anti-rabbit IgG H&L (Alexa Fluor® 488, 1: 1000) for 1 h and the nuclei were stained with DAPI for 15 min. Images were captured using a fluorescence microscope (Leica) and analyzed using ImageJ software.
Immunohistochemistry and Nissl staining
For immunohistochemistry, brain tissues were fixed with 4% paraformaldehyde and then permeabilized for 1 h in PBS with 0.2% Triton X 100 and 10% BSA at room temperature. Then, the frozen sections were incubated with primary antibodies at 4 °C overnight. The following day, the tissues were washed three times with 1× PBS. Then, the sections were incubated in 3% H2O2 to eliminate endogenous peroxidase activity.
Following three-time washes in 1× PBS, the sections were incubated with horseradish peroxidase (HRP)-conjugated polyclonal rabbit Ig G (Cell Signaling Technology, sections were rinsed with distilled water, and dehydrated in in a graded series of alcohol (70, 95, and 100%) . Tissue slices were transparentized with xylene for 5 min, and covered with cover slips by using neutral balsam (non-florescent). Next, the slices were observed and photographed under a microscope. The numbers of normal neurons were quantified by Image-Pro Plus 6 software.
Western blot analysis
The cells and the brain tissue were lysed, and the protein concentration was quantified by a BCA protein assay kit (Beyotime, China) according to the manufacturer's instructions. A quantity of 20-40 μg of total proteins was separated by 8-10% SDS-PAGE, and and transferred to polyvinylidene difluoride membranes and incubated with the primary antibodies (Table S1 ) at 4 °C overnight. After incubation with horseradish peroxidase-conjugated goat/mouse anti-rabbit IgG (1:1000) for 1 h at room temperature, the membranes were visualized by enhanced chemiluminescence (Affinity, China) scanned by an imaging system and then quantified using ImageJ software.
Reverse transcription-polymerase chain reaction (RT-PCR)
Total RNA from cells and brain tissues was extracted using TRIzol reagent (Beyotime, China) according to the manufacturer's instructions. Total RNA was reverse transcribed into cDNA using Hifair TM II 1st strand cDNA synthesis SuperMix kit (YeaSen, Shanghai, China), and RT-PCR was performed using SuperReal PreMix Plus (TianGen, Beijing, China) according to the manufacturer's instructions. cDNA was J o u r n a l P r e -p r o o f Journal Pre-proof subsequently amplified by PCR with specific primers (Table S2 ). The Ct values were normalized to β-actin, and the data were analyzed by using the 2 -ΔΔCt method.
Behavioral test

Morris water maze (MWM)
The MWM test was conducted as described previously (Zhao et al., 2019) to evaluate the memory and learning performance. Using video tracking software, behavioral tests were recorded daily at 6 h after drug injection. The test was performed three times a day for 5 days during the training period (Days 21-25), with three randomized starting points. Each test lasted for 1 min or ended as soon as the mouse reached the submerged platform. After two days of rest (Day 26-27), latency was measured to assess the time taken to reach the hidden platform on 4 consecutive days (Days 28-32). To evaluate memory consolidation, a probe test was conducted 24 h after the water maze test (Day 33) by removing the platform and allowing the mice to swim freely for 1 min.
Consolidated spatial memory was evaluated by analyzing the time spent in the target quadrant area and the crossing numbers and time over the previously hidden platform.
Open field test (OFT)
The OFT was performed to evaluate the locomotor activity of the mice as previously described (Oliveira-Lima et al., 2019) . The mice were individually placed into the center of an open field apparatus (30 × 30 × 60 cm) with nine virtual quadrants (10 × 10 cm each). At 24 h after drug administration, each mouse was permitted to freely explore for 6 min including 2 min of adaptation to the apparatus and 4 min of testing.
The number of crossing, grooming, rearing and the total distance were analyzed by J o u r n a l P r e -p r o o f Journal Pre-proof blinded observers to reduce bias. The device was cleaned with 5% alcohol to avoid odor clues after each test.
Pole test (PT)
The PT was conducted to measure the motor coordination of the mice as previously reported . Briefly, the mice were subjected to two days of training before testing. The test was performed at 24 h after drug treatment. The following three times were recorded: the time it took for the mouse to swivel from the upper half to the lower half , the time it took for the mouse to climb down from the upper half to the bottom of the lower half, and the time it took for the mouse to complete the two steps above.
Statistical analysis
The statistical analysis was performed with one-way ANOVA followed by Tukey's test. A p value < 0.05 was considered statistically significant. All figures were generated by using GraphPad Prism 5 software.
Results
indicating that 10 nM DHT inhibited microglial activation, as previously reported (Yao et al., 2017) . Therefore, we further determine whether pretreatment with DHT reduced proinflammatory cytokines and mediators in LPS-stimulated microglial cells. We showed that DHT significantly reduced LPS-induced iNOS, NO and TNF-α expression levels in BV2 cells ( Fig. 1a-c) , and decreased the expression levels of COX-2, PGE2 and IL-1β in LPS-stimulated primary microglia ( Fig. 3a-c ). Consistently, we also observed that DHT significantly reduced LPS-induced TNF-α, IL-1β, IL-6, iNOS and COX-2 mRNA levels in BV2 cells ( Fig. 1d -h) and primary microglia ( Fig. 3d-h) . These data suggest that DHT exerts an anti-inflammatory effect in activated microglia.
DHT suppressed the TLR4-mediated NF-κB and MAPK p38 signaling pathways in LPS-treated BV2 cells and primary microglia
The microglial proinflammatory response is attributed to the activation of TLR4 by LPS, which triggers downstream inflammatory signaling pathways, including NF-κB and MAPK, leading to protein phosphorylation and nuclear translocation, and ultimately to the production of proinflammatory cytokines and mediators (Lehnardt et al., 2003) . By evaluating the effects of DHT on these signaling pathways in microglia, we found that DHT suppressed LPS-induced increases in the protein levels of TLR4, and MyD88 and phospho-NF-κB p65 (p-P65) in BV2 cells ( Fig. 2a-b ), as well as the protein levels of TLR4, and phospho-MAPK p38 (p-P38) in primary microglia ( Fig.   4a ). To further determine the whether TLR4-mediated NF-κB and MAPK signaling was required for DHT-mediated anti-inflammatory effects, we assessed the effect of CLI-095, a TLR4 inhibitor, on both LPS and DHT-treated microglia as previously described J o u r n a l P r e -p r o o f Journal Pre-proof . The results showed that CLI-095 and DHT had similar inhibitory effects on the expression of TNF-α, p-P65, iNOS and NO in LPS-stimulated BV2 cells ( Fig. 2c-f ), and the expression of p-P38, COX-2, IL-1β and PGE2 in LPS-stimulated primary microglia ( Fig. 2b-e ); furthermore, DHT combined with CLI-095 further inhibited the expression of these proinflammatory mediators compared with that of the CLI-095 + LPS group, suggesting that DHT suppressed NF-κB and MAPK activation in microglia mainly through downregulation of TLR4 expression.
DHT protected SH-SY5Y neurons from activated microglia-induced neurotoxicity
LPS-stimulated microglial activation damages to neurons. Thus, we investigated the neuroprotective effects of DHT in neurons exposed to toxic effects of activated microglia. Our findings revealed that conditioned medium from LPS-treated BV2 cells and primary microglia cultures decreased the viability of SH-SY5Y cells, while the conditioned medium from the microglial cultures were treated with DHT prior to LPS treatment increased it SH-SY5Y cell viability ( Fig. 5b-c) . Moreover, the same concentration of DHT and LPS as in the microglial supernatants had no effect on the viability of SH-SY5Y cells (Fig. 5a ). These results indicate that proinflammatory cytokines released into the culture medium by microglia upon LPS stimulation decrease the viability of SH-SY5Y cells, while DHT pretreatment counters these effects.
Effect of DHT on the activation of microglia and astrocytes in LPS-injected mouse brains
According to the above in vitro findings, we examined whether DHT regulated the J o u r n a l P r e -p r o o f Journal Pre-proof LPS-induced activation of microglia and astrocytes in vivo. LPS-injected mice showed a significant increase in the number of GFAP-and Iba1-reactive cells, whereas castration markedly increased these cells in the cortex and hippocampus. Interestingly, DHT supplementation in castrated mice restored microglial and astrocyte activation ( Fig. 6a ). Consistent with the immunohistochemical results, Western blot analysis also showed that DHT regulated Iba-1 and GFAP protein levels in LPS-injected mouse brains ( Fig. 6b ). These data indicate that DHT modulates microglial and astrocyte activation in LPS-induced neuroinflammation.
Effects of DHT on LPS-induced systemic and brain inflammation
Systemic LPS injection affects inflammatory cytokine production in the serum and brain (Oliveira-Lima et al., 2019) . We investigated the effect of DHT on the inflammatory reaction in LPS-stimulated mice. We observed that LPS induced a significant increase in TNF-α, IL-1β and IL-6 in the serum (Fig. 7a -c) and brain homogenates ( Fig. 7d-f ); castration substantially amplified the LPS-induced release of these cytokines, but was the cytokine levels were dramatically restored by the administration of DHT. Similarly, DHT also modulated the mRNA expression of the anti-inflammatory cytokines IL-10, and IL-13, but failed to affect IL-4 transcription ( Fig. 7g-i) . Moreover, the protein expression of iNOS and COX-2 was increased in LPS-injected mice, and DHT administration abrogated the further increase in these proteins in the cortex and hippocampus of LPS-treated castrated mice (Fig. 7j ). These data suggest that DHT regulates the LPS-mediated inflammatory response systemically and in the brain.
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Effects of DHT on TLR4-mediated NF-κB and MAPK pathway activation in
LPS-injected mouse brains
The in vitro findings revealed that DHT inhibited the TLR4-mediated NF-κB and MAPK pathways in LPS-treated microglia. Thus, we further investigated whether DHT regulated the activation of these inflammatory signaling pathways in LPS-injected mouse brains (Fig. 8 ). Our results indicated that LPS treatment increased the expression of TLR4, p-P65, p-P38, p-JNK, and p-ERK ( Fig. 8 b-c, f-g), but had no evident effect on the expression of p-AKT ( Fig. 8 e) . Castration significantly promoted the LPSinduced activation of these proteins in the brain but these effects were abrogated by DHT supplementation (Fig. 8) . These results suggest that DHT modulates the TLR4mediated NF-κB and MAPK inflammation signaling pathways in LPS-injected mouse brains.
Effects of DHT on behavioral activity in LPS-treated mice
Acute LPS treatment also affects movement in mice, including motor activity and locomotor activity (Oliveira-Lima et al., 2019) . Thus, we evaluated whether DHT affected these behavioral activities in LPS-injected mice. Exposure to LPS remarkably decreased the numbers of crossing ( Fig. 9a ), grooming ( Fig. 9b ), rearing ( Fig. 9c ) and the total distance moved ( Fig. 9d ). Moreover, castration further significantly reduced the numbers of crossing and grooming and total distance moved; and DHT markedly improved the total distance in LPS-treated castrated mice ( Fig. 9a-d ), suggesting that DHT regulates the locomotor activity in LPS-injected mice. In the pole test, castration and DHT treatment had no evident impact on the time it took LPS-treated mice to turn J o u r n a l P r e -p r o o f Journal Pre-proof completely downward ( Fig. 9e ), but castration significantly prolonged the time it took the LPS-treated mice to place their four paws on the floor which was evidently shortened by DHT administration (Fig. 9e ), indicating that DHT improves the motor coordination in mice following LPS injection. Overall, these results indicate that DHT could improves behavioral activities in LPS-treated mice.
Effects of DHT on Aβ deposition and neuronal damage in LPS-treated mouse brains
Low dose LPS injection causes chronic inflammatory damage to neurons, amyloidβ (Aβ) production, synaptic loss and neuronal apoptosis (Chen et al., 2019; Wu et al., 2019) . We thus examined the effect of DHT on the expression of Aβ, apoptotic and synaptic proteins in the mouse brain. Castration accelerated the LPS-induced increase in Aβ formation (Fig. 10a ) in the hippocampus, pro-apoptotic protein caspase-3 in both the hippocampus and cortex compared to those of control group, as well as enhanced the decrease in the ratio of anti-to pro-apoptotic molecules (Bcl-2/Bax) in the cortex ( Fig. 10b ), but DHT treatment significantly blocked the castration-mediated amplification effect in LPS-injected mouse brains ( Fig. 10a-b ). In addition, LPS markedly reduced the protein level of synaptophysin (Fig. 10c ) in the brain, which was further decreased by castration in the cortex but had no effect in the hippocampus. DHT supplementation markedly reversed the effect of castration both in the hippocampus and cortex (Fig. 10c ). Consistently, Nissl staining revealed that LPS treatment caused neuronal loss in the hippocampus and cortex (Fig. 10d) . In castrated mice, LPS further reduced the numbers of neurons in the cortex, but DHT administration significantly J o u r n a l P r e -p r o o f Journal Pre-proof increased neuronal survival in both hippocampus and cortex (Fig. 10d) . These results suggest that DHT regulates Aβ deposition and protects against LPS-induced synaptic damage and neuronal loss in the mouse brain.
Effects of DHT on cognitive function in LPS-treated mice
LPS-induced neuronal damage contributes to cognitive impairment (Zhao et al., 2019) . We investigated the effect of DHT on spatial and learning behavior in LPStreated mice by using the MWM test. The time course of the learning curve revealed that LPS-injected mice arrived at the hidden platform significantly more slowly than the control mice from day 29 to day 32, and castration prolonged the time to reach the location of the platform in LPS-injected mice, although there was not significant difference ( Fig. 11a-b ). However, DHT supplementation after castration significantly decreased the time taken by LPS-treated castrated mice to arrive at the platform ( Fig.   11a-b ). When the platform was removed on day 33, the average escape latency (Fig.   11c ), time spent in the target quadrant ( Fig. 11d) and crossing numbers over the platform site ( Fig. 11e ) in LPS-treated mice were significantly prolonged compared with those of the control group. However, castration had no evident effect on these parameters, whereas DHT administration markedly improved all of these parameters in LPS-treated castrated mice ( Fig. 11c-e ). These behavioral parameters were not affected by motor function, because there was no significant difference in the average speed of these mice among the five groups (Fig. 11d ). Taken together, these results suggest that DHT ameliorates the LPS-induced spatial and learning impairment. How does DHT downregulate proinflammatory mediators? Previous studies have demonstrated that androgen treatment of macrophages and endothelial cells in vitro decreased the expression of TLR4 at the transcriptional and translational levels (Norata et al., 2010; Norata et al., 2006; Rettew et al., 2008) , and androgen supplementation abolished the increase in TLR4 protein expression of castrated animals (Leimgruber et al., 2013) . Thus, DHT might suppress the expression of TLR4 on the cell surface and deactivate downstream signaling pathways to inhibit the neuroinflammatory response.
LPS binds to TLR4 and activates downstream inflammatory signaling cascades
including NF-κB and MAPKs (Lu et al., 2008) . Consistent with previous findings that DHT inhibits the expression of NF-κB and the subsequent inflammatory response (Gonzales et al., 2009; Norata et al., 2006) , we further observed that, in LPS-stimulated microglia, DHT inhibited the activation of the NF-κB p65 and MAPK p38 pathways, which was primarily TLR4-dependent. Furthermore, DHT regulated the phosphorylation of p65, p38, ERK and JNK, but had no effect on the expression of pathogenesis of neurodegenerative diseases, including AD and PD. As an important component of senile plaques in AD, Aβ is a causative factor and induces neuronal loss through activation of apoptotic pathways (Lei and Renyuan, 2018) . A study reported that the upregulation of Aβ1-42 was accompanied by an increase in caspase-3 and Bax, and a decrease in Bcl-2 in systemic LPS-injected mouse brains (Chen et al., 2017; Wu et al., 2019) . Analogous to these results, we observed that LPS treatment resulted in increases in Aβ1-42, caspase-3 and the ratio of Bax/Bcl-2 in the brain, and DHT modulated the expression of these proteins, suggesting anti-amyloidogenic and antiapoptotic effects of DHT in LPS-induced neuroinflammation. The mechanism by which DHT reduces LPS-mediated Aβ deposition and neuronal apoptosis might be that by regulating the activity of Aβ hydrolases and degradation enzymes, as well as by facilitating microglial phagocytosis of Aβ (Lei and Renyuan, 2018) . In addition, synaptotoxicity of LPS was reported to be associated with the synaptic protein synaptophysin, which is implicated in synaptic plasticity and cognitive function (Rehman et al., 2019; Zhou et al., 2019) . In the present study, we showed that LPS administration decreased synaptophysin in the brain, which was regulated by DHT, indicating that DHT mitigates LPS-induced synaptic damage. Further Nissl staining revealed that DHT also attenuated the decrease in neurons in the hippocampus and cortex of LPS-induced mouse brains. Therefore, these results suggest that DHT exerts neuroprotective effects in LPS-induced neuroinflammation.
Neuronal loss in the hippocampus and cortex is closely related to cognitive and behavioral dysfunction. Accumulating evidence indicates that systemic LPS injection J o u r n a l P r e -p r o o f Journal Pre-proof in mice induces cognitive deficits, including spatial learning and memory impairment, as measured by MWM, which is the most popular test of hippocampal-dependent cognitive functions (Chen et al., 2019; Zhao et al., 2019) . Moreover, age-related depletion of androgens is associated with cognitive decline in elderly men and androgen supplementation is beneficial for cognitive function (Drummond et al., 2009; Mohamad et al., 2018) . In the current study, using the MWM, we observed that LPS treatment led to increased escape latency, a reduced proportion of time spent in the target quadrant and reduced platform crossing times. DHT administration improved these parameters in LPS-treated castrated mice, suggesting that DHT improves cognitive impairments in LPS-treated castrated mice. Our results also supported the observation that castration alone has no effect on the visible platform test and swimming speed in the MWM (Hajali et al., 2015) . In addition, previous studies have shown that LPS administration in mice affects locomotor and motor activity . Herein, our results showed that acute LPS injection reduced the locomotor activity and motor willingness in castrated mice, which were improved by DHT. Pole test also suggested that DHT supplementation in castrated mice had benefits on LPS-induced motor incoordination.
One explanation might be that DHT protects acetylcholinesterase neurons from LPS challenge, but the mechanism by which DHT improves LPS-induced motor dysfunction is unclear and requires further investigation. Take together, these results indicate that DHT improves the cognitive deficits and behavioral disturbance. Zhao, J., Bi, W., Xiao, S., Lan, X., Cheng, X., Zhang, J., Lu, D., Wei, W., Wang, Y., Li, H., Fu, Y., Zhu, L., 2019 
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